The numbers I am coming up with based on those assumptions are truly mind boggling, and are far in excess of anything being discussed here so far. While I have included some assumptions on sales of Trofinetide in the rest of the world, I have not included any ROW sales for 2591. I have assumed similar partnering arrangements, upfront payments and royalty rates for 2591 in each of the indications being currently investigated as a base case. I am very interested to know if anyone thinks my assumptions are out of the ballpark, unreasonable widely optimistic etc. What would you change?
Share Price, page-8692
-
- There are more pages in this discussion • 3,175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.76 |
Change
0.150(1.10%) |
Mkt cap ! $1.784B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $5.043M | 365.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $13.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.78 | 2834 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |